Larson Financial Group’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-15
Closed -$1K 739
2020
Q1
$1K Hold
15
﹤0.01% 501
2019
Q4
$1K Hold
15
﹤0.01% 532
2019
Q3
$1K Hold
15
﹤0.01% 506
2019
Q2
$1K Hold
15
﹤0.01% 459
2019
Q1
$1K Hold
15
﹤0.01% 452
2018
Q4
$1K Buy
+15
New +$1.01K ﹤0.01% 432

Other funds holding PJP

Larson Financial Group's PJP Position: Q2 2020 in Review

Larson Financial Group sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2020, closing a stake of 15 shares — an estimated $1K sold.

Larson Financial Group first reported a position in PJP in Q4 2018 and held it in 6 quarters. The position peaked at $1K in Q1 2020. 86 funds tracked by Wall St. Rank hold PJP as of Q2 2020.

  • Larson Financial Group reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2020 after selling out during the quarter.
  • Larson Financial Group sold 15 Invesco Pharmaceuticals ETF shares in Q2 2020, an estimated $1K.
  • Larson Financial Group first reported a position in Invesco Pharmaceuticals ETF in Q4 2018 and held it in 6 quarters.
  • Larson Financial Group's Invesco Pharmaceuticals ETF position peaked at $1K in Q1 2020.
  • 86 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2020.

Based on Larson Financial Group's 13F filing for Q2 2020, filed 10 Jul 2020.